Search by Drug Name or NDC
NDC 16714-0119-03 Tobramycin Inhalation Solution 300 mg/5mL Details
Tobramycin Inhalation Solution 300 mg/5mL
Tobramycin Inhalation Solution is a RESPIRATORY (INHALATION) INHALANT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by NorthStar RxLLC. The primary component is TOBRAMYCIN.
Product Information
| NDC | 16714-0119 |
|---|---|
| Product ID | 16714-119_f6d6a715-0341-9698-53c2-57466c491e60 |
| Associated GPIs | 07000070002520 |
| GCN Sequence Number | 037042 |
| GCN Sequence Number Description | tobramycin in 0.225% sod chlor AMPUL-NEB 300 MG/5ML INHALATION |
| HIC3 | W1F |
| HIC3 Description | AMINOGLYCOSIDE ANTIBIOTICS |
| GCN | 61551 |
| HICL Sequence Number | 016926 |
| HICL Sequence Number Description | TOBRAMYCIN IN 0.225 % SODIUM CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | Tobramycin Inhalation Solution |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Tobramycin Inhalation Solution |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INHALANT |
| Route | RESPIRATORY (INHALATION) |
| Active Ingredient Strength | 300 |
| Active Ingredient Units | mg/5mL |
| Substance Name | TOBRAMYCIN |
| Labeler Name | NorthStar RxLLC |
| Pharmaceutical Class | Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207080 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 16714-0119-03 (16714011903)
| NDC Package Code | 16714-119-03 |
|---|---|
| Billing NDC | 16714011903 |
| Package | 14 POUCH in 1 CARTON (16714-119-03) / 4 AMPULE in 1 POUCH / 5 mL in 1 AMPULE (16714-119-02) |
| Marketing Start Date | 2020-05-21 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 2.08139 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | TOBRAMYCIN 300 MG/5 ML AMPULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis